Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Jul 2023 – 20 Aug 2026, limited by LIC MF Nifty Next 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | LIC MF Nifty Next 50 Index Fund | Nifty 50 |
|---|---|---|
| 31 Jul 2023 | ₹100.00 | ₹100.00 |
| 01 Nov 2023 | ₹96.66 | ₹96.13 |
| 02 Feb 2024 | ₹123.43 | ₹110.63 |
| 05 May 2024 | ₹145.17 | ₹113.78 |
| 06 Aug 2024 | ₹155.28 | ₹121.46 |
| 07 Nov 2024 | ₹155.97 | ₹122.50 |
| 08 Feb 2025 | ₹140.56 | ₹119.27 |
| 12 May 2025 | ₹143.90 | ₹126.18 |
| 13 Aug 2025 | ₹148.08 | ₹124.63 |
| 14 Nov 2025 | ₹155.18 | ₹131.16 |
| 15 Feb 2026 | ₹153.04 | ₹128.94 |
| 19 May 2026 | ₹153.78 | ₹119.56 |
| 20 Aug 2026 | ₹166.40 | ₹122.67 |
| Metric | LIC · Direct NAV ₹60.98 Very High risk ★★★★☆ | Category median Index Funds · 375 funds |
|---|---|---|
| +9.81% | +5.66% | |
| +19.86% | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| +18.13% | +7.67% | |
| +11.75% | — | |
| +19.86% | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 18.38% | 13.97% | |
| 0.73 | 0.24 | |
| 0.98 | 0.36 | |
| -26.43% | -16.12% | |
| Nifty 50 | — | |
| +10.38% | +0.84% | |
| 1.30 | 1.00 | |
| 144.0% | 102.2% | |
| 95.1% | 97.2% | |
| 0.32% | 0.36% | |
| ₹103.89Cr | ₹177.09Cr | |
| None | — | |
| None | — | |
| ₹200 | — | |
| ₹5.00K | — | |
| 38% | 35% | |
| Sumit Bhatnagar | — | |
| 31 Jul 2023 | — | |
| 50 | — | |
| 32.2% | — | |
| 0.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.